FDA Clearance Tracker · P230023
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis
Last checked: Nov 19, 2026Latest source record: Jan 12, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jan 12, 2024
Approved
Time to decision
177 days
Received Jul 19, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P230023
- Device name
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis
- Applicant
- W. L. Gore & Associates, Inc.
- Applicant location
- Flagstaff, AZ
- Received
- Jul 19, 2023
- Decided
- Jan 12, 2024
- Decision
- Approved
- Supplements
- 12 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis. This device is indicated for endovascular repair in patients with thoracoabdominal aortic aneurysms and high-surgical risk patients with pararenal aortic aneurysms who have appropriate anatomy.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QZK (Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for W. L. Gore & Associates, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- GORE® VIABAHN® VBX Balloon Expandable EndoprosthesisPMA supplement
P160021-S051 · Decided Oct 8, 2026 · 244 days after receipt · Panel Track
Device type: Iliac covered stent, arterial (PRL) · Cardiology
- GORE® VIABAHN® FORTEGRA Venous StentBreakthroughPMA
P250017 · Decided Dec 19, 2025 · 182 days after receipt
Device type: Stent, vena cava (QTL) · Cardiology
K250410 · Decided Jun 2, 2025 · 109 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.